# Efficacy and Tolerability of Carbamazepine CR in Diabetic Neuropathy Pain

> **NCT01089855** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 123 (actual)

## Conditions studied

- Neuropathic Pain

## Interventions

- **DRUG:** Carbamazepine

## Key facts

- **NCT ID:** NCT01089855
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-07
- **Final completion:** —
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2017-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01089855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01089855, "Efficacy and Tolerability of Carbamazepine CR in Diabetic Neuropathy Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01089855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*